DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

Information source: University of Oslo
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

Intervention: MRI of the small bowel (Procedure)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: University of Oslo

Official(s) and/or principal investigator(s):
Nils-Einar Kløw, Prof. MD, Study Director, Affiliation: Ulleval Universitetssykehus

Summary

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution. Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Clinical Details

Official title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- above 18 years

- known Crohns disease or strong suspicion.

- need of a small bowel examination

Exclusion Criteria:

- pregnant

- electrolyte disturbances.

- Any MRI contraindications.

Locations and Contacts

Ulleval Universitets sykehus, Kirkeveien 166, Oslo 0407, Norway
Additional Information

Starting date: November 2004
Last updated: September 7, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017